AAAAAA

   
Results: 1-25 | 26-40 |
Results: 26-40/40
Differential behavior of VEGF receptor expression and response to TNP-470 in two immortalized human endothelial cell lines
Authors: Seki, M Toi, M Kobayashi, K Shitara, K Umezawa, K Seon, BK Kan, M Rhim, JS
Citation: M. Seki et al., Differential behavior of VEGF receptor expression and response to TNP-470 in two immortalized human endothelial cell lines, INT J ONCOL, 17(3), 2000, pp. 525-533
Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues
Authors: Mori, K Hasegawa, M Nishida, M Toma, H Fukuda, M Kubota, T Nagasue, N Yamana, H Chung, KHY Ikeda, T Takasaki, K Oka, M Kameyama, M Toi, M Fujii, H Kitamura, M Murai, M Sasaki, H Ozono, S Makuuchi, H Shimada, Y Onishi, Y Aoyagi, S Mizutani, K Ogawa, M Nakao, A Kinoshita, H Tono, T Imamoto, H Nakashima, Y Manabe, T
Citation: K. Mori et al., Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues, INT J ONCOL, 17(1), 2000, pp. 33-38
Power Doppler sonography of breast masses: Correlation of Doppler spectralparameters with tumor angiogenesis and histologic growth pattern
Authors: Tozaki, M Toi, M Miyamoto, Y Fukuda, K
Citation: M. Tozaki et al., Power Doppler sonography of breast masses: Correlation of Doppler spectralparameters with tumor angiogenesis and histologic growth pattern, J ULTR MED, 19(9), 2000, pp. 593-600
An immunohistochemical study of developing glomeruli in human fetal kidneys
Authors: Naruse, K Fujieda, M Miyazaki, E Hayashi, Y Toi, M Fukui, T Kuroda, N Hiroi, M Kurashige, T Enzan, H
Citation: K. Naruse et al., An immunohistochemical study of developing glomeruli in human fetal kidneys, KIDNEY INT, 57(5), 2000, pp. 1836-1846
Endocrine therapies for patients with recurrent breast cancer: Predictive factors for responses to first- and second-line endocrine therapies
Authors: Kurebayashi, J Sonoo, H Inaji, H Nishimura, R Iino, Y Toi, M Kobayashi, S Saeki, T
Citation: J. Kurebayashi et al., Endocrine therapies for patients with recurrent breast cancer: Predictive factors for responses to first- and second-line endocrine therapies, ONCOL-BASEL, 59, 2000, pp. 31-37
Somatic mutations of LKB1 and beta-catenin genes in gastrointestinal polyps from patients with Peutz-Jeghers syndrome
Authors: Miyaki, M Iijima, T Hosono, K Ishii, R Yasuno, M Mori, T Toi, M Hishima, T Shitara, N Tamura, K Utsunomiya, J Kobayashi, N Kuroki, T Iwama, T
Citation: M. Miyaki et al., Somatic mutations of LKB1 and beta-catenin genes in gastrointestinal polyps from patients with Peutz-Jeghers syndrome, CANCER RES, 60(22), 2000, pp. 6311-6313
Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration
Authors: Ueno, T Toi, M Koike, M Nakamura, S Tominaga, T
Citation: T. Ueno et al., Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration, BR J CANC, 83(2), 2000, pp. 164-170
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with eitheradjuvant chemotherapy or hormone therapy
Authors: Gasparini, G Toi, M Miceli, R Vermeulen, PB Dittadi, R Biganzoli, E Morabito, A Fanelli, M Gatti, C Suzuki, H Tominaga, T Dirix, LY Gion, M
Citation: G. Gasparini et al., Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with eitheradjuvant chemotherapy or hormone therapy, CA J SCI AM, 5(2), 1999, pp. 101-111
Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer
Authors: Toi, M Ueno, T Matsumoto, H Saji, H Funata, N Koike, M Tominaga, T
Citation: M. Toi et al., Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer, CLIN CANC R, 5(5), 1999, pp. 1131-1137
Circulating soluble Fas concentration in breast cancer patients
Authors: Ueno, T Toi, M Tominaga, T
Citation: T. Ueno et al., Circulating soluble Fas concentration in breast cancer patients, CLIN CANC R, 5(11), 1999, pp. 3529-3533
Endogenous interleukin-12: Relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinoma
Authors: Toi, M Gion, M Saji, H Asano, M Dittadi, R Gilberti, S Locopo, N Gasparini, G
Citation: M. Toi et al., Endogenous interleukin-12: Relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinoma, INT J ONCOL, 15(6), 1999, pp. 1169-1175
Significance of membrane type 1 matrix metalloproteinase expression in breast cancer
Authors: Ishigaki, S Toi, M Ueno, T Matsumoto, H Muta, M Koike, M Seiki, M
Citation: S. Ishigaki et al., Significance of membrane type 1 matrix metalloproteinase expression in breast cancer, JPN J CANC, 90(5), 1999, pp. 516-522
Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol
Authors: Saji, S Nakashima, S Hayashi, S Toi, M Saji, S Nozawa, Y
Citation: S. Saji et al., Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol, JPN J CANC, 90(2), 1999, pp. 210-218
Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells
Authors: Kumeda, SI Deguchi, A Toi, M Omura, S Umezawa, K
Citation: Si. Kumeda et al., Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells, ANTICANC R, 19(5B), 1999, pp. 3961-3968
Metalloproteinases and tissue inhibitors of metalloproteinases
Authors: Toi, M Ishigaki, S Tominaga, T
Citation: M. Toi et al., Metalloproteinases and tissue inhibitors of metalloproteinases, BREAST CANC, 52(1-3), 1998, pp. 113-124
Risultati: 1-25 | 26-40 |